Q4 2024 Viemed Healthcare Inc Earnings Call Transcript
Key Points
- Viemed Healthcare Inc (VMD) reported a record revenue performance with a 20% year-over-year increase for Q4 and a 23% increase for the full year 2024.
- The company experienced strong growth in its core Vent business, which accounted for 55% of Q4 revenue and 56% for the year.
- The sleep business saw a nearly 10% sequential increase in sleep therapy patients, contributing to a 43% increase in 2024 compared to 2023.
- Viemed Healthcare Inc (VMD) has a strong balance sheet with $55 million available on credit facilities and no net debt, providing significant financial flexibility.
- The company is projecting net revenue growth of 16% for 2025, with adjusted EBITDA expected to grow by 10%, indicating a positive outlook for the coming year.
- The adjusted EBITDA margin declined year-over-year and sequentially, primarily due to shifts in product and service mix.
- Free cash flow decreased to $11.6 million in 2024 from $21.7 million in 2023, impacted by increased cash taxes and Philips receivable adjustments.
- The staffing business, while strategically important, contributes less to gross margin and introduces variability in top-line results.
- CapEx increased significantly due to the vent exchange program and growth in vent patients, impacting net cash flow.
- The company faces uncertainty regarding potential impacts from the new administration's healthcare policies and tariffs, which could affect operations.
Greetings and welcome to the Viemed Healthcare year-end 2024 earnings call. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to our host, Trey Fitzgerald, Chief Financial Officer. Thank you. You may begin.
Thank you, and good morning, everyone. We appreciate you joining us today. Please note before we begin that these remarks, this conference call may include forward-looking statements under the US federal securities laws or forward-looking information under applicable Canadian securities legislation which we collectively refer to as forward-looking statements.
Such statements reflect the company's current views and intentions with respect to future results or events that are subject to certain risks and uncertainties which could cause actual results or events to vary from those indicated in forward-looking statements. Examples of such risks and uncertainties are disclosed in our disclosure documents filed with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
